middle.news
Algorae Advances Australian Market Entry with TGA Dossier Acceptance
9:48am on Thursday 2nd of April, 2026 AEDT
•
Pharmaceuticals
Read Story
Algorae Advances Australian Market Entry with TGA Dossier Acceptance
9:48am on Thursday 2nd of April, 2026 AEDT
Key Points
TGA accepts Algorae’s initial registration dossier for evaluation
First of seven generic medicines to enter Australian regulatory process
Licence and supply agreements secured with Sakar Healthcare and Cadila Pharmaceuticals
Multiple further TGA submissions planned alongside commercial initiatives
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ALGORAE PHARMACEUTICALS (ASX:1AI)
OPEN ARTICLE